| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/15/2006 | EP1633395A1 Functionally reconstituted viral membranes containing adjuvant |
| 03/15/2006 | EP1633381A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 03/15/2006 | EP1633316A2 Antibodies that immunospecifically bind to trail receptors |
| 03/15/2006 | EP1633309A2 Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 03/15/2006 | EP1512004B1 Method for mapping and eliminating t-cell epitopes |
| 03/15/2006 | EP1370589B1 Rationally designed antibodies |
| 03/15/2006 | EP1246905B1 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 03/15/2006 | EP1162997B1 Staphylococcus antigen and vaccine |
| 03/15/2006 | EP1068315B1 Therapeutic agent for ngf |
| 03/15/2006 | EP1045914B1 Testis-specific human svph1-8 proteinase |
| 03/15/2006 | EP1044022B1 Compositions and methods for targeted delivery of factors |
| 03/15/2006 | EP1001810B1 Pharmaceutical composition with neurotrophic-like biological activity |
| 03/15/2006 | EP0942973B1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 03/15/2006 | EP0733069B1 Purified primate ctla-8 antigens and related reagents |
| 03/15/2006 | EP0733064B1 Nucleic acids encoding a house dust mite allergen, (der p iii), and uses therefor |
| 03/15/2006 | CN1748143A Transgenic mice expressing human cd20 and/or cd16 |
| 03/15/2006 | CN1747971A Antibody ('11c7') anti nogo a and its pharmaceutical use |
| 03/15/2006 | CN1747970A Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 03/15/2006 | CN1747969A Immunoglobulin variants and uses thereof |
| 03/15/2006 | CN1746300A Phosphokinase and use thereof |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746187A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1746186A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1245513C Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 03/15/2006 | CN1245419C Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 03/14/2006 | US7012547 Electronic vehicle toll collection system and method |
| 03/14/2006 | US7012135 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 03/14/2006 | US7012134 Dendritic enriched secreted lymphocyte activation molecule |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012131 Pro1410 polypeptides |
| 03/14/2006 | US7012127 site-directed mutagenesis; for prevention and treatment of sepsis and other endotoxin-related disorders |
| 03/14/2006 | US7011974 Using hybridomas cells; gene expression; monoclonal antibodies |
| 03/14/2006 | US7011967 Seripancrin |
| 03/14/2006 | US7011831 Recombinant α-galactosidase A therapy for Fabry disease |
| 03/14/2006 | CA2324348C Methods and compositions for peptide synthesis |
| 03/14/2006 | CA2171317C Method for purifying egg yolk immunoglobulins |
| 03/09/2006 | WO2006026445A1 Production of polypeptides |
| 03/09/2006 | WO2006025580A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 03/09/2006 | WO2006025345A1 Antihuman baff antibody |
| 03/09/2006 | WO2006024867A2 Method for improved transgene expression |
| 03/09/2006 | WO2006024752A1 Modified hiv-1 peptides and use thereof in the detection of anti-hiv antibodies |
| 03/09/2006 | WO2006024497A1 Affinity- plus ion exchange- chromatography for purifying antibodies |
| 03/09/2006 | WO2006002627A9 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 03/09/2006 | WO2005118646A9 Epitope directed selection of antibodies to murine tissue factor |
| 03/09/2006 | WO2005118644A3 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/09/2006 | WO2005102387A3 Therapeutic use of anti-cs1 antibodies |
| 03/09/2006 | WO2005075514A3 Method for producing antibodies |
| 03/09/2006 | WO2005063820A3 Il-7 fusion proteins |
| 03/09/2006 | WO2005052004A3 Compositions comprising polypeptides |
| 03/09/2006 | WO2004094612A3 Cancer specific monoclonal antibodies |
| 03/09/2006 | WO2004071446A3 Immune complexes |
| 03/09/2006 | WO2004050850A3 Antibodies directed to phospholipase a2 and uses thereof |
| 03/09/2006 | US20060053501 Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060053496 Caterpiller gene family |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052592 Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 03/09/2006 | US20060052584 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052322 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 03/09/2006 | US20060052301 Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereof |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051853 Human MEKK proteins, corresponding nucleic acid molecules and uses therefor |
| 03/09/2006 | US20060051850 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/09/2006 | US20060051839 DNA expression vectors and methods of use |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051835 Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease |
| 03/09/2006 | US20060051823 specific antigenic proteins and peptides unique to Treponema pallidum; diagnosis of syphilis; immunoassay of acidic repeat protein/immunogens |
| 03/09/2006 | US20060051822 Methods for detecting Bacillus thuringiensis cryET33 and cry ET34 polypeptides |
| 03/09/2006 | US20060051817 Uses of Gangliosides GM1 and/or asialo-GM1 substances simulating the carbohydrate portion of the gangliosides; early diagnosis of cancer; carcinoma |
| 03/09/2006 | US20060051813 Diagnostic method for a transmissible spongiform encephalopathy or prion disease |
| 03/09/2006 | US20060051792 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051774 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051381 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 03/09/2006 | US20060051370 Microorganisms for therapy |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051359 Recombinant immunotoxin and use in treating tumors |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051352 CEA binding agents and compositions to reverse CEA-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof |
| 03/09/2006 | US20060051351 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051348 Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
| 03/09/2006 | US20060051347 Process for concentration of antibodies and therapeutic products thereof |
| 03/09/2006 | US20060051346 Humanized anti-CD4 antibody with immunosuppressive properties |
| 03/09/2006 | US20060051345 Method for treating multiple sclerosis |
| 03/09/2006 | US20060051344 Antibody and utilization of the same |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | CA2581208A1 Affinity- plus ion exchange- chromatography for purifying antibodies |
| 03/09/2006 | CA2578995A1 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |
| 03/09/2006 | CA2578141A1 Production of polypeptides |
| 03/09/2006 | CA2577678A1 Humanized anti-beta7 integrin subunit antibodies and uses therefor |